期刊文献+

改良型大鼠梗阻性黄疸肝切除术后肝衰模型的建立 被引量:5

Rat model of postoperative liver failure induced by modified method of hepatectomy with obstructive jaundice
原文传递
导出
摘要 目的建立一种改良的Wistar大鼠梗阻性黄疸肝切除术后肝衰竭模型。方法通过切断胆总管建立梗阻性黄疸模型,探索最佳梗阻时间。在梗阻14d后,行胆道内引流,分离出70%肝脏分别阻断0、15、30、45min,切除未行阻断的余肝,建立肝衰模型,观察生化指标、病理改变及生存率。结果梗阻14d组更加适合下一步造模。随着阻断时间的延长肝功能进行性下降,各组间差异有统计学意义(P〈0.05),其中30min组24h死亡率达80%,有典型肝衰症状,组织病理学符合肝衰特点。结论对梗阻性黄疸大鼠行肝脏血流阻断及肝切除可建立能较大程度模拟临床过程的外科型肝衰竭模型。 Objective To establish a modified operative method-induced postoperative liver failure in Wistar rats. Methods An obstructive jaundice model with bile duct cut off in rats was established to study the optimum obstruction time. Besides, a rat model of liver failure was established. After obstruction for 14 days, the rats were subjected to internal biliary drainage. Afterwards, the vessel of the left and mid- die lobe of liver (occupied 70% of the total volume) for different time, then resected the other lobes of liver without ischemia. To observe and compare the biochemical indexes, the histopathology, and the survival time. Results 14 d group is more suitable for the next treatment. The liver function of the rats were de- creased with prolonging the time of ischemia, the differences between groups were significant ( P 〈 0. 05 ). The mortality was as high as 80% after 24 hours in 30 min group, and this group had the typical symptoms of liver failure and the pathology was significant Conclusion The experimental model of postoperative liver failure could be established by partially hepatectomized after hepatic devascularization in Wistar rats with obstructive jaundice. It showed similar clinical pathophvsiological changes in hunman beings.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2013年第3期640-642,共3页 Chinese Journal of Experimental Surgery
关键词 肝衰竭 手术 模型 动物 Liver failure Operation Model, animal
  • 相关文献

参考文献10

  • 1Lau SH, Lau WY. Current therapy of hilar cholangiocarcinoma. Hepa- tobiliary Pancreat Dis Int,2012,11 : 12-17.
  • 2Clary B, Jarnigan W, Pitt H, et al. Hilar cholangiocarcinoma. J Gas- trointest Surg ,2004,8:298-502.
  • 3黄志强.肝门部胆管癌外科治疗面临的问题与出路[J].中华实验外科杂志,2004,21(7):773-775. 被引量:78
  • 4Suda K, Ohtsuka M, Ambiru S, et al. Risk factors of liver dysfunction after extended hepatic resection in biliary tract malignancies. Am J Surg,2009 ,197 :752-758.
  • 5Arai T, Naqino M, Nimura Y. Hepatic failure following resection of cholestatic liver. Nihon Geka Gakkai Zasshi ,2004,105:664-668.
  • 6Van der Gaag NA,Kloek JJ, de Castro SM, et al. Preoperative biliary drainage in patients with obstructive jaundice :history and current sta- tus. J Gastrointest Surg,2009,13 : 814 -820.
  • 7Kondo S, Hirano S, Ambo , et al. Forty consecutive resections of hi- lar cholangiocarcinoma with no postoperative mortality and no passtive dnctal mavgins:results of prospective study. Ann Surg,2004,240:95- 101.
  • 8彭耀荣,李文滨,褚忠华,梁明娟,林青,王捷.大鼠同种骨髓间充质细胞门静脉输注对肝大部分切除肝衰模型术后肝功能、生存率的影响[J].中华实验外科杂志,2011,28(11):1887-1889. 被引量:3
  • 9黄华,陈钟,吴振宇,祝文彩,陈玉泉.微囊化猪肝细胞移植治疗大鼠急性肝衰竭[J].中华实验外科杂志,2005,22(12):1469-1471. 被引量:8
  • 10Terblanche J, Hickman R. Animal models of fulminant hepatic fail- ure. Dig Dis Sci, 1991,36:770-774.

二级参考文献15

  • 1张晓玲,戴尅戎,汤亭亭,张超,周芸,周光炎.未分化骨髓间充质干细胞的免疫学特性研究[J].中华实验外科杂志,2006,23(2):135-137. 被引量:29
  • 2Gilchrist ES,Plevris JN.Bone marrow-derived stem cells in liver repair:10 years down the line.Liver Transp1,2010,16:118-129.
  • 3Pathikonda M,Munoz SJ.Acute liver failure.Ann Hepatol,2010,9:7-14.
  • 4Tanb R.Liver regeneration:from myth to mechanism.Nat Rev Mol Cell Biol,2004,5:836-847.
  • 5Sell S.Heterogeneity and plasticity of hepatocyte lineage cells.Hepatology,2001,33:738-750.
  • 6Saito T,Kuang JQ,Bittira B,et al.Xenotransplant cardiac chimera:immune tolerance of adult stem cells.Ann Thorac Surg,2002,74:19-24.
  • 7Crop M,Baan CC,Korevaar SS,et al.Human adipose tissue-derived mesenchymal stem cells induce explosive T-cell proliferation.Stem Cells Dev,2010,19:1843-1853.
  • 8Uccelli A,Moretta L,Pistoia V.Mesenchymal stem cells in health and disease.Nat Rev Immunol,2008,8:726-736.
  • 9van Poll D,Parekkadan B,Cho CH,et al.Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo.Hepatology,2008,47:1634-1643.
  • 10Weber A,Groyer-Picard MT,Franco D,et al.Hepatocyte transplantation in animal models.Liver Transpl,2009,15:7-14.

共引文献85

同被引文献64

引证文献5

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部